1. Field of the Invention
Embodiments of this invention relates to methods for using phosphate and/or nitrate brines to reduce hydrate formation in flowlines under conditions conducive for hydrate formation in the absence of the phosphate and/or nitrate brine. In certain embodiments, the phosphate and/or nitrate brines may include compatible anti-corrosion additives.
2. Description of the Related Art
Gas hydrate is a solid comprising a mixture of water and hydrocarbon gas such as methane. Such mixtures are predominantly water with occluded gaseous hydrocarbons such as methane, ethylene, propylene, etc., normally present in minor amounts. The hydrates may also include other gas components or gas contaminants such as carbon dioxide and hydrogen sulfide. Gas hydrate formation is ubiquitous in offshore drilling for and transportation of resources such as gas and/or crude oil, because subsea temperature and pressure conditions are favorable for or conducive to hydrate formation. In certain environments, the temperature is at or below about 35° F. Thus, wellheads, drilling and production annuli or control lines may become plugged or blocked with an accumulation of gas hydrate. Consequently, drilling fluids may lose their functionality, because hydrate formation may lead to an imbalance in composition of the fluid (less water than originally formulated), increased loss of circulation due to the changes in fluid properties, increased flow back, sudden exposure of the fluids at well surface conditions, which may lead to implosions, and great concern in flow-assurance, as well as real potential of abandoning a well or halting an operation operation are problems familiar to those knowledgeable in the art.
In prior art, gas hydrate is prevented or managed by a number of different methods. One method involves the use of salts and alcohols (glycols, methanol, etc.) (see, e.g., Sloan, E. D. et. al., JPT, December 2009; pp 89-94) to lower a freezing point temperature of the fluid. Other methods involve using low doses of hydrate inhibitors capable of altering hydrate formation kinetics (delaying the rate of hydrate formation) or capable of reducing or preventing hydrate precipitation by keeping hydrate in solution, so-called anti-agglomerants (see, e.g., Proceedings of the 6th ICGH 2008, Vancouver, BC, CA, Jul. 6-10, 2008). Other methods involve managing hydrate agglomeration mechanically by shearing (see, e.g., U.S. Pat. No. 6,774,276; Published International Application No. WO/2007/095399 & United States Published Application 2004/0129609). Other methods involve insulating and heating pipelines to reduce hydrate formation (see, e.g., U.S. Pat. No. 6,070,417). Another method uses high cost organic brines that have a low pour point temperature to reduce or inhibit hydrate formation such as formate brines.
While there are many different methods to address hydrate formation, there is still a need in the art for fluids that reduced or inhibit hydrate formation under conditions conducive to hydrate formation in the absence to the fluids and that are environmentally benign and less costly than fluids known to reduce or inhibit hydrate formation such as expensive formate brines.
Embodiments of the present invention provide methods for inhibiting hydrate formation, where the methods include using a phosphate brine and/or a nitrate brine as a base fluid in downhole operations under conditions conducive for hydrate formation. In certain embodiments, a fluid including a phosphate brine and/or a nitrate brine may also include capable anti-corrosion additives and/or neutralization additives. The fluid will also include other components depending on the application to which the fluids are being applied. For example, in the case of drilling fluids, the fluids may include capable drilling additives such as foaming agents for underbalanced or pressure managed drilling.
The invention can be better understood with reference to the following detailed description together with the appended illustrative drawings in which like elements are numbered the same:
The term “substantially” means that the value or effect is at least 80% of being complete. In certain embodiments, the term means that the value of effect is at least 85% of being complete. In certain embodiments, the term means that the value of effect is at least 90% of being complete. In certain embodiments, the term means that the value of effect is at least 95% of being complete. In certain embodiments, the term means that the value of effect is at least 99% of being complete.
The term “about” means that the value or effect is at least 90% of being complete. In certain embodiments, the term means that the value of effect is at least 95% of being complete. In certain embodiments, the term means that the value of effect is at least 99% of being complete.
The term “ppg” means pounds per gallon (lb/gal) and is a measure of density.
The term “SG” means specific gravity.
The term “under-balanced and/or managed pressure drilling fluid” means a drilling fluid having a hydrostatic density (pressure) lower or equal to a formation density (pressure). For example, if a known formation at 10,000 ft (True Vertical Depth—TVD) has a hydrostatic pressure of 5,000 psi or 9.6 lbm/gal, an under-balanced drilling fluid would have a hydrostatic pressure less than or equal to 9.6 lbm/gal. Most under-balanced and/or managed pressure drilling fluids include at least a density reduction additive. Other additive many include a corrosion inhibitor, a pH modifier and a shale inhibitor.
The inventors have found that gas hydrate inhibiting fluids can be formulated to reduce or inhibit hydrate formation under conditions conducive for hydrate formation, where the fluids include an effective amount of a phosphate and/or nitrate brine. The brine reduces or inhibits hydrates formation. A small concentration of a composition of this invention introduced into a brine fluid changes a freezing point temperature of the brine fluid eliminating the formation of hydrates. The fluids may be foamed or unfoamed. For foamed fluid, an effective amount of a foaming system and a gas is added to the fluid to form a foam having desired properties.
Current teaching provides a novel non-halide brines designed to lower a pour point temperature of a fluid rending the fluid unsusceptible to hydrate formation. In addition, brine-compatible corrosion inhibiting additives may be used when needed. Instead of contending with highly expensive formate (sodium, potassium or cesium) brines, sodium, potassium, calcium or zinc (or their blends) phosphate brines or nitrate brines maybe used. As such, activity of using the brine sources or systems has no significant impact on the environment, because the brines are easy to handle and maybe disposed indiscriminately. Unlike when alcohols, amphipathics or oleophilic inhibitors are employed, brine-produced fluid separation is facile.
Phosphate Brines
Suitable phosphate brines for use in the present invention include, without limitation, phosphoric acid brines, polyphosphoric acid brines, alkali metal brines, alkaline earth metal phosphate brines, transition metal phosphate brines, and mixtures or combinations thereof. Exemplary examples alkali metal phosphate brines include mono lithium hydrogen phosphate brines, mono hydrogen phosphate brines, mono potassium hydrogen phosphate brines, mono rubidium hydrogen phosphate brines, mono cesium hydrogen phosphate brines, di-lithium hydrogen phosphate brines, di-hydrogen phosphate brines, di-potassium hydrogen phosphate brines, di-rubidium hydrogen phosphate brines, di-cesium hydrogen phosphate brines, and mixture or combinations thereof. Exemplary examples of alkaline earth metal phosphate brines include magnesium phosphate brines, calcium hydrogen phosphate brines, and mixture or combinations thereof. Exemplary examples of transition metal phosphate brines include zinc phosphate brines, and mixture or combinations thereof.
It should be recognized that if one wants to form a mixed phosphate brine, then one would use a suitable hydrogen phosphate and a suitable base. For example, if one wanted to prepare a potassium-cesium mixed phosphate brine, then one could start with a potassium hydrogen phosphate and cesium hydroxide or cesium hydrogen phosphate and potassium hydroxide. One can also start with cesium, potassium hydrogen phosphate and neutralize with either potassium or cesium hydroxide depending on the brine to be produced. It should also be recognized that the phosphate brines can include more than two metals as counterions by using a mixture of hydrogen phosphates and/or a mixture of bases.
Nitrate Brines
Suitable nitrate brines useful in the present invention include, without limitation, alkali metal nitrate brines, alkaline earth metal nitrate brines, transition metal nitrate brines, and mixtures or combinations thereof. Exemplary examples of alkali metal nitrate brines include lithium nitrate, sodium nitrate, potassium nitrate, rubidium nitrate, cesium nitrate, and mixture or combinations thereof. Exemplary examples of alkaline earth metal nitrate brines include magnesium nitrates, calcium nitrates, and mixture or combinations thereof. Exemplary examples of transition metal nitrate brines include zinc nitrate brines, and mixture or combinations thereof.
Brine Specific Corrosion Inhibitors
Suitable neutralizing agents for neutralizing phosphate brines include, without limitation, acids, anhydrides, other compounds capable of neutralizing basic phosphate brines, or mixtures or combinations thereof. Suitable acids include, without limitation, organic acids, organic acid anhydrides, inorganic acids, inorganic acid anhydrides or mixtures and combinations thereof. Exemplary acids include, without limitations, carboxylic acids (mono, di or poly), halogen containing acids such as hydrochloric acid (HCl), hydrobromic acid (HBr), etc., sulfur containing acids such as sulfuric acid, sulfonic acids, sulfinyl acids, etc., phosphoric containing acids such as phosphoric acid, polyphosphoric acid, etc. or mixtures and combinations thereof. Exemplary carboxylic acids include, without limitation, saturated carboxy acids having from 1 to about 20 carbon atoms, unsaturated carboxy acids having from about 2 to about 20 carbon atoms, aromatic acids having from about 5 to about 30 carbon atoms, saturated dicarboxy acids having from 1 to about 20 carbon atoms, unsaturated dicarboxy acids having from about 2 to about 20 carbon atoms, aromatic diacids having from about 5 to about 30 carbon atoms, saturated polycarboxy acids having from 1 to about 20 carbon atoms, unsaturated polycarboxy acids having from about 2 to about 20 carbon atoms, aromatic polyacids having from about 5 to about 30 carbon atoms, or mixtures and combinations thereof. Exemplary sulfonic acids include, without limitation, alkyl sulfonic acids, alkenyl sulfonic acids, aryl sulfonic acids, where the alkyl groups include 1 to about 20 carbon atoms, the alkenyl groups include 2 to about 20 carbon atoms and the aryl groups include 5 to about 30 carbon atoms. In all of these structures, one or more of the carbon atoms may be replaced by hetero atoms including boron, nitrogen, oxygen, sulfur, or mixtures thereof and one or more of the required hydrogen atoms to complete the valency may be replaced by a halogen including fluorine, chlorine, or bromine, a hydroxyl group, an ether group, an amine, an amide, or mixtures thereof. Exemplary anhydrides include, without limitation, anhydrides prepared from one or more of the acids listed above. In certain embodiments, the acids include methane sulfonic acid (Lutropur MSA—LMSA) from BASF Corp. USA, benzoic acid from Sigma-Aldrich Co. USA, hydrochloric acid, glycolic acid, formic acid, polyphosphoric acid, or mixtures and combinations thereof.
Suitable quaternary salts and amine for use in the additive systems as corrosion inhibitors of this invention include, without limitation, quaternary ammonium salts (R1R2R3R4N+A−), quaternary phosphonium salts (R1R2R3R4P+A−), amines (R1R2R3N), phosphines (R1R2R3P), and mixtures or combinations thereof, where the R1, R2, R3 and R4 are the same or different and are carbyl groups having between 1 and about 20 carbon atoms (saturated, unsaturated, cyclic, acyclic, aromatic, or mixed) and sufficient hydrogen atoms to satisfy the valence, where one or more carbon atoms may be replaced by a hetero atom or group selected from oxygen, sulfur, amido, boron, or mixtures thereof, and one or more of the hydrogen atoms can be replace by halogens, alkoxdies, or mixtures thereof and where A−is a counterion. Exemplary examples of counterions include hydroxide (OH—), halogens (F−, Cl−, Br−, I−) sulfate (SO42−), nitrate (NO3−), other counterions or mixtures thereof. Exemplary examples of quaternary and amines include other additive such as CORSAF SF (CSF) available from Tetra Technologies, Inc. USA, OxBan HB™ (OBHB) available from Tetra Technologies, Inc. USA, CorrFoam™ 1 (CF-1) available from Weatherford International, USA, Triaminononane Crude (TAN) available from NOVA Molecular Technologies, Inc. USA and BARDAC® LF, a quaternary biocides, available from Lonza Inc. Allendale, NJ.
Suitable bases include, without limitation, alkali metal hydroxides, alkaline earth metal and mixtures or combinations thereof. Exemplary examples include lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, magnesium hydroxide and mixtures or combinations thereof.
Suitable Drilling Fluid Components
Suitable aqueous base fluids includes, without limitation, seawater, freshwater, saline water or such makeup system containing up to about 30% crude oil.
Suitable foaming agents for use in this invention include, without limitation, any foaming agent suitable for foaming aquesous based drilling fluids. Exemplary examples of foaming agents include, without limitation KleanFoam™, DuraFoam™, FMA-100™, TransFoam™ (all available from Weatherford International) or mixture or combinations.
Suitable polymers for use in this invention include, without limitation, any polymer soluble in the aqueous base fluid. Exemplary polymers include, without limitation, a polymer comprising units of one or more (one, two, three, four, five, . . . , as many as desired) polymerizable salts of mono-olefins or di-olefins. Exemplary examples includes, without limitation, natural polymers (starch, hydroxymethyl cellulose, xanthan, guar, etc.) and derivates; co-polymerizable monomers such as acrylates (acrylic acid, methyl acrylate, ethyl acrylate, etc.), methacrylates (methacrylic acid, methyl methacrylate, ethyl methacrylate, etc), 2-acrylamindomethylpropane sulfonic acid, vinylacetate, acrylamide, or the like, provided of course that the resulting polymer is soluble in the water base fluid.
Gases
Suitable gases for foaming the foamable, ionically coupled gel composition include, without limitation, nitrogen, carbon dioxide, or any other gas suitable for use in formation fracturing, or mixtures or combinations thereof.
Other Types of Corrosion Inhibitors
Suitable corrosion inhibitor for use in this invention include, without limitation: quaternary ammonium salts e.g., chloride, bromides, iodides, dimethylsulfates, diethylsulfates, nitrites, bicarbonates, carbonates, hydroxides, alkoxides, or the like, or mixtures or combinations thereof; salts of nitrogen bases; or mixtures or combinations thereof. Exemplary quaternary ammonium salts include, without limitation, quaternary ammonium salts from an amine and a quaternarization agent, e.g., alkylchlorides, alkylbromide, alkyl iodides, alkyl sulfates such as dimethyl sulfate, diethyl sulfate, etc., dihalogenated alkanes such as dichloroethane, dichloropropane, dichloroethyl ether, epichlorohydrin adducts of alcohols, ethoxylates, or the like; or mixtures or combinations thereof and an amine agent, e.g., alkylpyridines, especially, highly alkylated alkylpyridines, alkyl quinolines, C6 to C24 synthetic tertiary amines, amines derived from natural products such as coconuts, or the like, dialkylsubstituted methyl amines, amines derived from the reaction of fatty acids or oils and polyamines, amidoimidazolines of DETA and fatty acids, imidazolines of ethylenediamine, imidazolines of diaminocyclohexane, imidazolines of aminoethylethylenediamine, pyrimidine of propane diamine and alkylated propene diamine, oxyalkylated mono and polyamines sufficient to convert all labile hydrogen atoms in the amines to oxygen containing groups, or the like or mixtures or combinations thereof. Exemplary examples of salts ofnitrogen bases, include, without limitation, salts of nitrogen bases derived from a salt, e.g.: C1 to C8 monocarboxylic acids such as formic acid, acetic acid, propanoic acid, butanoic acid, pentanoic acid, hexanoic acid, heptanoic acid, octanoic acid, 2-ethylhexanoic acid, or the like; C2 to C12 dicarboxylic acids, C2 to C12 unsaturated carboxylic acids and anhydrides, or the like; polyacids such as diglycolic acid, aspartic acid, citric acid, or the like; hydroxy acids such as lactic acid, itaconic acid, or the like; aryl and hydroxy aryl acids; naturally or synthetic amino acids; thioacids such as thioglycolic acid (TGA); free acid forms of phosphoric acid derivatives of glycol, ethoxylates, ethoxylated amine, or the like, and aminosulfonic acids; or mixtures or combinations thereof and an amine, e.g.: high molecular weight fatty acid amines such as cocoamine, tallow amines, or the like; oxyalkylated fatty acid amines; high molecular weight fatty acid polyamines (di, tri, tetra, or higher); oxyalkylated fatty acid polyamines; amino amides such as reaction products of carboxylic acid with polyamines where the equivalents of carboxylic acid is less than the equivalents of reactive amines and oxyalkylated derivatives thereof; fatty acid pyrimidines; monoimidazolines of EDA, DETA or higher ethylene amines, hexamethylene diamine (HMDA), tetramethylenediamine (TMDA), and higher analogs thereof; bisimidazolines, imidazolines of mono and polyorganic acids; oxazolines derived from monoethanol amine and fatty acids or oils, fatty acid ether amines, mono and bis amides of aminoethylpiperazine; GAA and TGA salts of the reaction products of crude tall oil or distilled tall oil with diethylene triamine; GAA and TGA salts of reaction products of dimer acids with mixtures of poly amines such as TMDA, HMDA and 1,2-diaminocyclohexane; TGA salt of imidazoline derived from DETA with tall oil fatty acids or soy bean oil, canola oil, or the like; or mixtures or combinations thereof.
Other Additives
The drilling fluids of this invention can also include other additives as well such as scale inhibitors, carbon dioxide control additives, paraffin control additives, oxygen control additives, or other additives.
Scale Control
Suitable additives for Scale Control and useful in the compositions of this invention include, without limitation: Chelating agents, e.g., Na+, K+ or NH4+ salts of EDTA; Na, K or NH4+ salts of NTA; Na+, K+ or NH4+ salts of Erythorbic acid; Na+, K+ or NH4+ salts of thioglycolic acid (TGA); Na+, K+ or NH4+ salts of Hydroxy acetic acid; Na+, K+ or NH4+ salts of Citric acid; Na+, K+ or NH4+ salts of Tartaric acid or other similar salts or mixtures or combinations thereof. Suitable additives that work on threshold effects, sequestrants, include, without limitation: Phosphates, e.g., sodium hexamethylphosphate, linear phosphate salts, salts of polyphosphoric acid, Phosphonates, e.g., nonionic such as HEDP (hydroxythylidene diphosphoric acid), PBTC (phosphoisobutane, tricarboxylic acid), Amino phosphonates of: MEA (monoethanolamine), NH3, EDA (ethylene diamine), Bishydroxyethylene diamine, Bisaminoethylether, DETA (diethylenetriamine), HMDA (hexamethylene diamine), Hyper homologues and isomers of HMDA, Polyamines of EDA and DETA, Diglycolamine and homologues, or similar polyamines or mixtures or combinations thereof; Phosphate esters, e.g., polyphosphoric acid esters or phosphorus pentoxide (P2O5) esters of: alkanol amines such as MEA, DEA, triethanol amine (TEA), Bishydroxyethylethylene diamine; ethoxylated alcohols, glycerin, glycols such as EG (ethylene glycol), propylene glycol, butylene glycol, hexylene glycol, trimethylol propane, pentaerythritol, neopentyl glycol or the like; Tris & Tetrahydroxy amines; ethoxylated alkyl phenols (limited use due to toxicity problems), Ethoxylated amines such as monoamines such as MDEA and higher amines from 2 to 24 carbons atoms, diamines 2 to 24 carbons carbon atoms, or the like; Polymers, e.g., homopolymers of aspartic acid, soluble homopolymers of acrylic acid, copolymers of acrylic acid and methacrylic acid, terpolymers of acylates, AMPS, etc., hydrolyzed polyacrylamides, poly malic anhydride (PMA); or the like; or mixtures or combinations thereof.
Carbon Dioxide Neutralization
Suitable additives for CO2 neutralization and for use in the compositions of this invention include, without limitation, MEA, DEA, isopropylamine, cyclohexylamine, morpholine, diamines, dimethylaminopropylamine (DMAPA), ethylene diamine, methoxy proplyamine (MOPA), dimethylethanol amine, methyldiethanolamine (MDEA) & oligomers, imidazolines of EDA and homologues and higher adducts, imidazolines of aminoethylethanolamine (AEEA), aminoethylpiperazine, aminoethylethanol amine, di-isopropanol amine, DOW AMP-90™, Angus AMP-95, dialkylamines (of methyl, ethyl, isopropyl), mono alkylamines (methyl, ethyl, isopropyl), trialkyl amines (methyl, ethyl, isopropyl), bishydroxyethylethylene diamine (THEED), or the like or mixtures or combinations thereof.
Paraffin Control
Suitable additives for Paraffin Removal, Dispersion, and/or paraffin Crystal Distribution include, without limitation: Cellosolves available from DOW Chemicals Company; Cellosolve acetates; Ketones; Acetate and Formate salts and esters; surfactants composed of ethoxylated or propoxylated alcohols, alkyl phenols, and/or amines; methylesters such as coconate, laurate, soyate or other naturally occurring methylesters of fatty acids; sulfonated methylesters such as sulfonated coconate, sulfonated laurate, sulfonated soyate or other sulfonated naturally occurring methylesters of fatty acids; low molecular weight quaternary ammonium chlorides of coconut oils soy oils or C10 to C24 amines or monohalogenated alkyl and aryl chlorides; quanternary ammonium salts composed of disubstituted (e.g., dicoco, etc.) and lower molecular weight halogenated alkyl and/or aryl chlorides; gemini quaternary salts of dialkyl(methyl, ethyl, propyl, mixed, etc.) tertiary amines and dihalogenated ethanes, propanes, etc. or dihalogenated ethers such as dichloroethyl ether (DCEE), or the like; gemini quaternary salts of alkyl amines or amidopropyl amines, such as cocoamidopropyldimethyl, bis quaternary ammonium salts of DCEE; or mixtures or combinations thereof. Suitable alcohols used in preparation of the surfactants include, without limitation, linear or branched alcohols, specially mixtures of alcohols reacted with ethylene oxide, propylene oxide or higher alkyleneoxide, where the resulting surfactants have a range of HLBs. Suitable alkylphenols used in preparation of the surfactants include, without limitation, nonylphenol, decylphenol, dodecylphenol or other alkylphenols where the alkyl group has between about 4 and about 30 carbon atoms. Suitable amines used in preparation of the surfactants include, without limitation, ethylene diamine (EDA), diethylenetriamine (DETA), or other polyamines. Exemplary examples include Quadrols, Tetrols, Pentrols available from BASF. Suitable alkanolamines include, without limitation, monoethanolamine (MEA), diethanolamine (DEA), reactions products of MEA and/or DEA with coconut oils and acids.
Oxygen Control
The introduction of water downhole often is accompanied by an increase in the oxygen content of downhole fluids due to oxygen dissolved in the introduced water. Thus, the materials introduced downhole must work in oxygen environments or must work sufficiently well until the oxygen content has been depleted by natural reactions. For system that cannot tolerate oxygen, then oxygen must be removed or controlled in any material introduced downhole. The problem is exacerbated during the winter when the injected materials include winterizers such as water, alcohols, glycols, Cellosolves, formates, acetates, or the like and because oxygen solubility is higher to a range of about 14-15 ppm in very cold water. Oxygen can also increase corrosion and scaling. In CCT (capillary coiled tubing) applications using dilute solutions, the injected solutions result in injecting an oxidizing environment (O2) into a reducing environment (CO2, H2S, organic acids, etc.).
Options for controlling oxygen content includes: (1) de-aeration of the fluid prior to downhole injection, (2) addition of normal sulfides to product sulfur oxides, but such sulfur oxides can accelerate acid attack on metal surfaces, (3) addition of erythorbates, ascorbates, diethylhydroxyamine or other oxygen reactive compounds that are added to the fluid prior to downhole injection; and (4) addition of corrosion inhibitors or metal passivation agents such as potassium (alkali) salts of esters of glycols, polyhydric alcohol ethyloxylates or other similar corrosion inhibitors. Exemplary examples oxygen and corrosion inhibiting agents include mixtures of tetramethylene diamines, hexamethylene diamines, 1,2-diaminecyclohexane, amine heads, or reaction products of such amines with partial molar equivalents of aldehydes. Other oxygen control agents include salicylic and benzoic amides of polyamines, used especially in alkaline conditions, short chain acetylene diols or similar compounds, phosphate esters, borate glycerols, urea and thiourea salts of bisoxalidines or other compound that either absorb oxygen, react with oxygen or otherwise reduce or eliminate oxygen.
Salt Inhibitors
Suitable salt inhibitors for use in the fluids of this invention include, without limitation, Na Minus Nitrilotriacetamide available from Clearwater International, LLC of Houston, Tex.
Introduction
In preparation for this hydrate dissociation evaluation, two brine solutions were submitted to Intertek Westport Technology Center, Houston, Tex. USA. Each fluid was then evaluated for hydrate dissociation temperatures at varying pressures using a synthetic gas supplied by Intertek Westport (Green Canyon Gas). These tests were performed in a high pressure Autoclave mixing cell.
Test Procedures
Approximately 175 mL of a test fluid were poured into an open Autoclave cell. The cell was sealed, evacuated, and purged using the test gas to remove the possibility of interference due to air contamination. The pressure was increased to test conditions. The fluid was then allowed to become gas saturate with mixing. Upon completion of the saturation process, the pressure was shut in and the cell temperature was reduced at approximately 10° F. per hour to minimum test conditions. The temperature was then maintained at minimum test conditions for an extended period of time to ensure a significant amount of hydrate formation had occurred. A temperature ramp is conducted back up to the initial starting temperature at approximately 6° F. per hour. Temperature and pressure data were collected using a data acquisition system. Three dissociation points were measured on each sample using this procedure at varying pressures to define the hydrate equilibrium curves.
Table I list the composition of the test gas.
Table II tabulates the hydrate equilibrium test results for a nitrate brine and a phosphate brine.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
The data presented in the tables and figures clearly demonstrates that the phosphate and nitrate brines are ideal candidates for preparing fluid for use under condition conducive for hydrate formation. The phosphate and nitrate brines show hydrate equilibrium curves similar to zinc bromide, potassium formate and sodium chloride brines, which are currently used as hydrate inhibitors. The phosphate and nitrate brines are lower cost and are relatively non-corrosive. In certain embodiments, the brines may include compatible anti-corrosion additives and/or neutralization additives to further reduce any corrosive propensity of the brines. The phosphate and nitrate brines of this invention may be added to drilling fluids, foamed drilling fluids, completion fluids, foamed completion fluids, production fluid or foamed production fluids at concentration sufficient to reduce or inhibit hydrate formation. Additionally, the drilling, completion or production fluids, foamed or unfoamed, may use the phosphate and nitrate brines of this invention as the base fluid.
All references cited herein are incorporated by reference. Although the invention has been disclosed with reference to its preferred embodiments, from reading this description those of skill in the art may appreciate changes and modification that may be made which do not depart from the scope and spirit of the invention as described above and claimed hereafter.
Number | Name | Date | Kind |
---|---|---|---|
2196042 | Timpson | Apr 1940 | A |
2390153 | Kern | Dec 1945 | A |
2805958 | Bueche et al. | Jul 1959 | A |
3059909 | Wise | Oct 1962 | A |
3163219 | Wyant et al. | Dec 1964 | A |
3301723 | Chrisp | Jan 1967 | A |
3301848 | Halleck | Jan 1967 | A |
3303896 | Tillotson et al. | Feb 1967 | A |
3317430 | Priestley et al. | May 1967 | A |
3565176 | Wittenwyler | Feb 1971 | A |
3856921 | Shrier et al. | Dec 1974 | A |
3888312 | Tiner et al. | Jun 1975 | A |
3933205 | Kiel | Jan 1976 | A |
3937283 | Blauer et al. | Feb 1976 | A |
3960736 | Free et al. | Jun 1976 | A |
3965982 | Medlin | Jun 1976 | A |
3990978 | Hill | Nov 1976 | A |
4007792 | Meister | Feb 1977 | A |
4052159 | Fuerst et al. | Oct 1977 | A |
4067389 | Savins | Jan 1978 | A |
4108782 | Thompson | Aug 1978 | A |
4112050 | Sartori et al. | Sep 1978 | A |
4112051 | Sartori et al. | Sep 1978 | A |
4112052 | Sartori et al. | Sep 1978 | A |
4113631 | Thompson | Sep 1978 | A |
4378845 | Medlin et al. | Apr 1983 | A |
4461716 | Barbarin et al. | Jul 1984 | A |
4479041 | Fenwick et al. | Oct 1984 | A |
4506734 | Nolte | Mar 1985 | A |
4514309 | Wadhwa | Apr 1985 | A |
4541935 | Constien et al. | Sep 1985 | A |
4549608 | Stowe et al. | Oct 1985 | A |
4561985 | Glass, Jr. | Dec 1985 | A |
4623021 | Stowe | Nov 1986 | A |
4654266 | Kachnik | Mar 1987 | A |
4657081 | Hodge | Apr 1987 | A |
4660643 | Perkins | Apr 1987 | A |
4683068 | Kucera | Jul 1987 | A |
4686052 | Baranet et al. | Aug 1987 | A |
4695389 | Kubala | Sep 1987 | A |
4705113 | Perkins | Nov 1987 | A |
4714115 | Uhri | Dec 1987 | A |
4718490 | Uhri | Jan 1988 | A |
4724905 | Uhri | Feb 1988 | A |
4725372 | Teot et al. | Feb 1988 | A |
4739834 | Peiffer et al. | Apr 1988 | A |
4741401 | Walles et al. | May 1988 | A |
4748011 | Baize | May 1988 | A |
4779680 | Sydansk | Oct 1988 | A |
4795574 | Syrinek et al. | Jan 1989 | A |
4817717 | Jennings, Jr. et al. | Apr 1989 | A |
4830106 | Uhri | May 1989 | A |
4846277 | Khalil et al. | Jul 1989 | A |
4848468 | Hazlett et al. | Jul 1989 | A |
4852650 | Jennings, Jr. et al. | Aug 1989 | A |
4869322 | Vogt, Jr. et al. | Sep 1989 | A |
4892147 | Jennings, Jr. et al. | Jan 1990 | A |
4926940 | Stromswold | May 1990 | A |
4938286 | Jennings, Jr. | Jul 1990 | A |
4978512 | Dillon | Dec 1990 | A |
5005645 | Jennings, Jr. et al. | Apr 1991 | A |
5024276 | Borchardt | Jun 1991 | A |
5067556 | Fudono et al. | Nov 1991 | A |
5074359 | Schmidt | Dec 1991 | A |
5074991 | Weers | Dec 1991 | A |
5082579 | Dawson | Jan 1992 | A |
5106518 | Cooney et al. | Apr 1992 | A |
5110486 | Manalastas et al. | May 1992 | A |
5169411 | Weers | Dec 1992 | A |
5224546 | Smith et al. | Jul 1993 | A |
5228510 | Jennings, Jr. et al. | Jul 1993 | A |
5246073 | Sandiford et al. | Sep 1993 | A |
5259455 | Nimerick et al. | Nov 1993 | A |
5330005 | Card et al. | Jul 1994 | A |
5342530 | Aften et al. | Aug 1994 | A |
5347004 | Rivers et al. | Sep 1994 | A |
5363919 | Jennings, Jr. | Nov 1994 | A |
5402846 | Jennings, Jr. et al. | Apr 1995 | A |
5411091 | Jennings, Jr. | May 1995 | A |
5424284 | Patel et al. | Jun 1995 | A |
5439055 | Card et al. | Aug 1995 | A |
5462721 | Pounds et al. | Oct 1995 | A |
5465792 | Dawson et al. | Nov 1995 | A |
5472049 | Chaffe et al. | Dec 1995 | A |
5482116 | El-Rabaa et al. | Jan 1996 | A |
5488083 | Kinsey, III et al. | Jan 1996 | A |
5497831 | Hainey et al. | Mar 1996 | A |
5501275 | Card et al. | Mar 1996 | A |
5551516 | Norman et al. | Sep 1996 | A |
5624886 | Dawson et al. | Apr 1997 | A |
5635458 | Lee et al. | Jun 1997 | A |
5649596 | Jones et al. | Jul 1997 | A |
5669447 | Walker et al. | Sep 1997 | A |
5674377 | Sullivan, III et al. | Oct 1997 | A |
5688478 | Pounds et al. | Nov 1997 | A |
5693837 | Smith et al. | Dec 1997 | A |
5711396 | Joerg et al. | Jan 1998 | A |
5722490 | Ebinger | Mar 1998 | A |
5744024 | Sullivan, III et al. | Apr 1998 | A |
5755286 | Ebinger | May 1998 | A |
5775425 | Weaver et al. | Jul 1998 | A |
5787986 | Weaver et al. | Aug 1998 | A |
5806597 | Tjon-Joe-Pin et al. | Sep 1998 | A |
5807812 | Smith et al. | Sep 1998 | A |
5833000 | Weaver et al. | Nov 1998 | A |
5853048 | Weaver et al. | Dec 1998 | A |
5871049 | Weaver et al. | Feb 1999 | A |
5877127 | Card et al. | Mar 1999 | A |
5908073 | Nguyen et al. | Jun 1999 | A |
5908814 | Patel et al. | Jun 1999 | A |
5964295 | Brown et al. | Oct 1999 | A |
5979557 | Card et al. | Nov 1999 | A |
5980845 | Cherry | Nov 1999 | A |
6016871 | Burts, Jr. | Jan 2000 | A |
6035936 | Whalen | Mar 2000 | A |
6047772 | Weaver et al. | Apr 2000 | A |
6054417 | Graham et al. | Apr 2000 | A |
6059034 | Rickards et al. | May 2000 | A |
6060436 | Snyder et al. | May 2000 | A |
6063972 | Duncum et al. | May 2000 | A |
6069118 | Hinkel et al. | May 2000 | A |
6123394 | Jeffrey | Sep 2000 | A |
6133205 | Jones | Oct 2000 | A |
6147034 | Jones et al. | Nov 2000 | A |
6162449 | Maier et al. | Dec 2000 | A |
6162766 | Muir et al. | Dec 2000 | A |
6169058 | Le et al. | Jan 2001 | B1 |
6228812 | Dawson et al. | May 2001 | B1 |
6247543 | Patel et al. | Jun 2001 | B1 |
6267938 | Warrender et al. | Jul 2001 | B1 |
6283212 | Hinkel et al. | Sep 2001 | B1 |
6291405 | Lee et al. | Sep 2001 | B1 |
6330916 | Rickards et al. | Dec 2001 | B1 |
6725931 | Nguyen et al. | Apr 2004 | B2 |
6756345 | Pakulski et al. | Jun 2004 | B2 |
6793018 | Dawson et al. | Sep 2004 | B2 |
6832650 | Nguyen et al. | Dec 2004 | B2 |
6875728 | Gupta et al. | Apr 2005 | B2 |
7055628 | Grainger et al. | Jun 2006 | B2 |
7140433 | Gatlin et al. | Nov 2006 | B2 |
7186353 | Novak | Mar 2007 | B2 |
7268100 | Kippie et al. | Sep 2007 | B2 |
7350579 | Gatlin et al. | Apr 2008 | B2 |
7392847 | Gatlin et al. | Jul 2008 | B2 |
7517447 | Gatlin | Apr 2009 | B2 |
7565933 | Kippie et al. | Jul 2009 | B2 |
7566686 | Kippie et al. | Jul 2009 | B2 |
7712535 | Venditto et al. | May 2010 | B2 |
7767628 | Kippie et al. | Aug 2010 | B2 |
7829510 | Gatlin et al. | Nov 2010 | B2 |
7886824 | Kakadjian et al. | Feb 2011 | B2 |
7915203 | Falana et al. | Mar 2011 | B2 |
7932214 | Zamora et al. | Apr 2011 | B2 |
7942201 | Ekstrand et al. | May 2011 | B2 |
7956017 | Gatlin et al. | Jun 2011 | B2 |
7956217 | Falana et al. | Jun 2011 | B2 |
7971659 | Gatlin et al. | Jul 2011 | B2 |
7989404 | Kakadjian et al. | Aug 2011 | B2 |
7992653 | Zamora et al. | Aug 2011 | B2 |
8011431 | van Petegen | Sep 2011 | B2 |
8012913 | Gatlin et al. | Sep 2011 | B2 |
8028755 | Darnell et al. | Oct 2011 | B2 |
8034750 | Thompson et al. | Oct 2011 | B2 |
8065905 | Sweeney et al. | Nov 2011 | B2 |
8084401 | Lukocs et al. | Dec 2011 | B2 |
8093431 | Falana et al. | Jan 2012 | B2 |
8097567 | Wilson, Jr. | Jan 2012 | B2 |
8099997 | Curr et al. | Jan 2012 | B2 |
8141661 | Kakadjian et al. | Mar 2012 | B2 |
8158562 | Wilson, Jr. et al. | Apr 2012 | B2 |
8172952 | Wanner et al. | May 2012 | B2 |
20020049256 | Bergeron, Jr. | Apr 2002 | A1 |
20020165308 | Kinniard et al. | Nov 2002 | A1 |
20030220204 | Baran, Jr. et al. | Nov 2003 | A1 |
20050045330 | Nguyen et al. | Mar 2005 | A1 |
20050092489 | Welton et al. | May 2005 | A1 |
20050137114 | Gatlin et al. | Jun 2005 | A1 |
20060194700 | Gatlin et al. | Aug 2006 | A1 |
20080251252 | Schwartz | Oct 2008 | A1 |
20080318812 | Kakadjian et al. | Dec 2008 | A1 |
20090250659 | Gatlin | Oct 2009 | A1 |
20090275488 | Zamora et al. | Nov 2009 | A1 |
20100077938 | Zamora et al. | Apr 2010 | A1 |
20100212905 | van Petegen | Aug 2010 | A1 |
20100252262 | Ekstrand et al. | Oct 2010 | A1 |
20100292108 | Kakadjian | Nov 2010 | A1 |
20100305010 | Falana et al. | Dec 2010 | A1 |
20100311620 | Kakadjian et al. | Dec 2010 | A1 |
20110001083 | Falana et al. | Jan 2011 | A1 |
20110005756 | van Petegen | Jan 2011 | A1 |
20110240131 | Parker | Oct 2011 | A1 |
20110247821 | Thompson et al. | Oct 2011 | A1 |
20110284247 | Zamora et al. | Nov 2011 | A1 |
20110284248 | Zamora et al. | Nov 2011 | A1 |
20120071366 | Falana et al. | Mar 2012 | A1 |
20120071367 | Falana et al. | Mar 2012 | A1 |
20120071370 | Falana et al. | Mar 2012 | A1 |
20120073813 | Zamora et al. | Mar 2012 | A1 |
20120137752 | Morrow | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
WO 2009141308 | Nov 2009 | WO |
Entry |
---|
U.S. Appl. No. 13/117,304, filed May 27, 2011, Falana et al. |
U.S. Appl. No. 13/247,985, filed Sep. 28, 2011, Veldman et al. |
U.S. Appl. No. 13/109,712, filed May 17, 2011, Falana et al. |
U.S. Appl. No. 13/102,053, filed May 6, 2011, Falana et al. |
U.S. Appl. No. 13/094,806, filed Apr. 26, 2011, Zamora et al. |
U.S. Appl. No. 13/052,947, filed Mar. 21, 2011, Kakadjian et al. |
U.S. Appl. No. 13/102,053, filed May 6, 2011, Kakadjian et al. |
U.S. Appl. No. 13/348,267, filed Jan. 1, 2012, Kakadjian et al. |
U.S. Appl. No. 13/249,819, filed Sep. 30, 2011, Falana et al. |
U.S. Appl. No. 13/348,279, filed Jan. 11, 2012, Falana et al. |
U.S. Appl. No. 13/348,267, filed Jan. 11, 2012, Kakadjian et al. |
Number | Date | Country | |
---|---|---|---|
20130178399 A1 | Jul 2013 | US |